Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxillary Nerve Block in Cleft Palate Surgery
NCT05495750Phase 4Completed
- Start
- Jun 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain and Systemic Inflammatory Response Syndrome (SIRS) (2 arms). Primary endpoint: Interleukin 6 serum level. Started Jun 2022; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative painSystemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT05495750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05495750.